Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 201–300 of 1,004

1. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19
   Raman Kumar, Himani Rathi, Afrozul Haq, Sunil J. Wimalawansa, Alpana Sharma · 2020 · Virus Research
2. Report 34: COVID-19 infection fatality ratio: estimates from seroprevalence
   N Brazeau, Robert Verity, Sara J. Jenks, Han Jing Fu, Charles Whittaker, Peter Winskill, Ilaria Dorigatti, Patrick G. T. Walker, Steven Riley, Ricardo Parolin Schnekenberg et al. · 2020 · Spiral (Imperial College London)
3. Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19
   Keller, Marla J, Kitsis, Elizabeth A, Arora, Shitij, Chen, Jen-Ting, Agarwal, Shivani, Ross, Michael J, Tomer, Yaron, Southern, William · 2020 · Journal of Hospital Medicine
4. COVID-19 and Dexamethasone
   William M. Stauffer, Jonathan D. Alpern, Patricia Frye Walker · 2020 · JAMA
5. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
   Antonio Olivas‐Martínez, José Luis Cárdenas-Fragoso, José Víctor Jiménez, Oscar Arturo Lozano-Cruz, Edgar Ortíz‐Brizuela, Víctor Hugo Tovar-Méndez, Carla Medrano-Borromeo, Alejandra Martínez-Valenzuela, Carla Marina Román-Montes, Bernardo Alfonso Martínez-Guerra et al. · 2021 · PLoS ONE
6. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19
   Milad Sharifpour, Srikant Rangaraju, Michael Liu, Darwish Alabyad, Fadi B. Nahab, Christina Creel-Bulos, Craig S. Jabaley · 2020 · PLoS ONE
7. Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study
   Esposito, Anthony J., Menon, Aravind A., Ghosh, Auyon J., Putman, Rachel K., Fredenburgh, Laura E., El-Chemaly, Souheil Y., Goldberg, Hilary J., Baron, Rebecca M., Hunninghake, Gary M., Doyle, Tracy J. · 2020 · American Journal of Respiratory and Critical Care Medicine
8. Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
   Michael A. Matthay, Bruce Thompson · 2020 · The Lancet Respiratory Medicine
9. Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities
   John P. A. Ioannidis, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis · 2021 · Environmental Research
10. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
    Donna R. R Rivera, Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu, Samuel M. Rubinstein, Brendan J. Lee, Toni K. Choueiri, Gilberto De Lima Lopes Jr. et al. · 2020 · Cancer Discovery
11. Impact of Heart Failure on the Clinical Course and Outcomes of Patients Hospitalized for COVID-19. Results of the Cardio-COVID-Italy Multicentre Study
    Daniela Tomasoni, Riccardo Maria Inciardi, Carlo Lombardi, Chiara Tedino, Piergiuseppe Agostoni, Pietro Ameri, Lucia Barbieri, Antonio Bellasi, Rita Camporotondo, Claudia Canale et al. · 2020 · European Journal of Heart Failure
12. COVID-19 versus Non–COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
    William Bain, Haopu Yang, Faraaz Ali Shah, Tomeka L. Suber, Callie M. Drohan, Nameer Al‐Yousif, Rebecca DeSensi, N. Bensen, Caitlin Schaefer, Brian R. Rosborough et al. · 2021 · Annals of the American Thoracic Society
13. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
    Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey Robert Baden, Bonnie Lee Bermas, Winn W Chatham, Stanley B. Cohen, Karen H. Costenbader, Ellen M. Gravallese et al. · 2020 · Arthritis & Rheumatology
14. Therapy for Early COVID-19
    Peter S. Kim, Sarah W. Read, Anthony S. Fauci · 2020 · JAMA
15. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell
    Serge Daniel Le Bon, Déborah Konopnicki, Nathalie Pisarski, Léa Prunier, Jerome Rene Lechien, Mihaéla Horoi · 2021 · European Archives of Oto-Rhino-Laryngology
16. Neutralizing Antibody Therapeutics for COVID-19
    A. Hurt, A. Wheatley · 2021 · Viruses
17. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave?
    Damien Contou, Megan Fraissé, Olivier Pajot, Jo-Anna Tirolien, Hervé Mentec, Gaëtan Plantefève · 2021 · Critical Care
18. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis
    Anthony Paulo Sunjaya, Sabine M. Allida, Gian Luca Di Tanna, Christine R. Jenkins · 2021 · Journal of Asthma
19. Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
    Baik, Alan H., Oluwole, Olalekan O., Johnson, Douglas B., Shah, Nina, Salem, Joe-Elie, Tsai, Katy K., Moslehi, Javid J. · 2021 · Circulation Research
20. COVID-19 and Cardiovascular Disease
    Mina K. Chung, David A. Zidar, Michael R. Bristow, Scott J. Cameron, Timothy An-thy Chan, Clifford V. Harding, Deborah H. Kwon, Tamanna K. Singh, John C. Tilton, Emily J. Tsai et al. · 2021 · Circulation Research
21. Musculoskeletal involvement of COVID-19: review of imaging
    Santhoshini Leela Ramani, Jonathan D. Samet, Colin K. Franz, Christine Hsieh, Cuong V. Nguyen, Craig Horbinski, Swati D. Deshmukh · 2021 · Skeletal Radiology
22. Impact of COVID-19 in solid organ transplant recipients
    Lara A. Danziger‐Isakov, Emily A. Blumberg, Oriol Manuel, Martina Sester · 2020 · American Journal of Transplantation
23. Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
    Peter Breining, Anne Lier Frølund, Jesper Falkesgaard Højen, Jesper Damsgaard Gunst, Nina Breinholt Stærke, Eva Aggerholm Sædder, Manuel Cases, Paul S Little, Lars Peter Nielsen, Ole Schmeltz Søgaard et al. · 2020 · Basic & Clinical Pharmacology & Toxicology
24. Challenges for Drug Repurposing in the COVID-19 Pandemic Era
    Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirò · 2020 · Frontiers in Pharmacology
25. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome
    Jiao Liu, Sheng Zhang, Xuan Dong, Zhongyi Li, Qianghong Xu, Huibin Feng, Jing Cai, Sisi Huang, Jun Guo, Lidi Zhang et al. · 2020 · Journal of Clinical Investigation
26. After 62 years of regulating immunity, dexamethasone meets COVID-19
    Derek W. Cain, John Anthony Cidlowski · 2020 · Nature reviews. Immunology
27. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
    Saamia Faruqui, Fidelis C. Okoli, Sonja K. Olsen, David M. Feldman, Harmit S. Kalia, James S Park, Carmen M. Stanca, Viviana Figueroa Diaz, Sarah Yuan, Nabil N. Dagher et al. · 2021 · The American Journal of Gastroenterology
28. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis
    Bingbing Li, Shan Zhang, Ruili Zhang, Xi Chen, Yong Wang, Changlian Zhu · 2020 · Frontiers in Pediatrics
29. High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
    David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp Moritz Lepper, Heinrike Wilkens, Robert Bals, Hermann Eichler, Barbara Christine Gärtner, Sören L. Becker et al. · 2020 · JCI Insight
30. The looming storm: Blood and cytokines in COVID-19
    Kaur, Supreet, Bansal, Rashika, Kollimuttathuillam, Sudarsan, Gowda, Anusha Manje, Singh, Balraj, Mehta, Dhruv, Maroules, Michael · 2021 · Blood Reviews
31. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
    Yi-Zhou Jiang, Limor Rubin, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Wenhua Zheng · 2021 · International Journal of Biological Sciences
32. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients
    Samantha M. Morrissey, Anne E. Geller, Xiaoling Hu, David A. Tieri, Chuanlin Ding, Christopher K. Klaes, Elizabeth A. Cooke, Matthew R. Woeste, Zachary C. Martin, Oscar Chen et al. · 2021 · JCI Insight
33. Immunosuppressive Drugs and COVID-19: A Review
    Tessa S Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum · 2020 · Frontiers in Pharmacology
34. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
    M Sreepadmanabh, Amit Kumar Sahu, Ajit G. Chande · 2020 · Journal of Biosciences
35. Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
    Anahita Sadeghı, Ali Asgari, Alireza Norouzi, Zahedin Kheiri, Amir Anushirvani, Mahnaz Montazeri, Hadiseh Hosamirudsai, Shirin Afhami, Elham Akbarpour, Rasoul Aliannejad et al. · 2020 · Journal of Antimicrobial Chemotherapy
36. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak
    Sabaka, P., Koščálová, A., Straka, I., Hodosy, J., Lipták, R., Kmotorková, B., Kachlíková, M., Kušnírová, A. · 2021 · BMC Infectious Diseases
37. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh et al. · 2020 · Annals of Clinical Microbiology and Antimicrobials
38. Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
    Malina A. Bakowski, Nathan Beutler, Karen C. Wolff, Melanie G. Kirkpatrick, Emily Chen, Tu-Trinh Nguyen, Laura Riva, Namir Shaabani, Mara Parren, James Ricketts et al. · 2021 · Nature Communications
39. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
    Nathan James Brendish, Stephen Poole, Vasanth V Naidu, Christopher Mansbridge, Nicholas Norton, Helen Wheeler, Laura Presland, Stephen P. Kidd, Nicholas Cortes, Florina Borca et al. · 2020 · The Lancet Respiratory Medicine
40. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
    Antoine Beurnier, Etienne‐Marie Jutant, Mitja Jevnikar, Athénaïs Boucly, Jérémie Pichon, Mariana Preda, Marie Frank, Jeremy Laurent, Christian Richard, Xavier Monnet et al. · 2020 · European Respiratory Journal
41. Major differences in ICU admissions during the first and second COVID-19 wave in Germany
    Christian Karagiannidis, Wolfram Windisch, Daniel Francis McAuley, Tobias Welte, Reinhard Busse · 2021 · The Lancet Respiratory Medicine
42. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles
    Akshamal Mihiranga Gamage, Kai Sen Tan, Wharton O. Y. Chan, Jing Liu, Chee Wah Tan, Yew Kwang Ong, Mark Kim Thye Thong, Anand Kumar Andiappan, Danielle E. Anderson, De Yun Wang et al. · 2020 · PLoS Pathogens
43. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease
    Keyvan Razazi, Romain Arrestier, Anne-Fleur Haudebourg, Brice Benelli, Guillaume Carteaux, Jean‐Winoc Decousser, Slim Fourati, Paul‐Louis Woerther, Frédéric Schlemmer, Anaïs Charles‐Nelson et al. · 2020 · Critical Care
44. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response
    Yongzhen Liu, Chao Qin, Youliang Rao, Chau Ngo, Joshua J. Feng, Jun Zhao, Shu Jie Zhang, Tingyu Wang, Jessica Carrière, Ali Can Savas et al. · 2021 · mBio
45. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
    Richard H. Hunt, James Edward East, Ángel Lanas, Peter Malfertheiner, Jack J. Satsangi, Carmelo Scarpignato, Gwilym James Webb · 2020 · Digestive Diseases
46. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
    Chunxue Bai, Sanjay Haresh Chotirmall, Jordi Rello, George A. Alba, Leo C. Ginns, Jerry A. Krishnan, Robert Rogers, Elisabeth M. Bendstrup, Pierre‐Régis Burgel, James Duncan Chalmers et al. · 2020 · European Respiratory Review
47. Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
    Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, Peng Ye, Hang Li, Liang Yu, Xiaoyang Zhou et al. · 2021 · Clinical and Translational Medicine
48. T cell immunobiology and cytokine storm of COVID‐19
    Xiao-Hua Luo, Yan Zhu, Jian Mao, R. Du · 2020 · Scandinavian Journal of Immunology
49. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
    Rodriguez-Garcia, Jose Luis, Sanchez-Nievas, Gines, Arevalo-Serrano, Juan, Garcia-Gomez, Cristina, Jimenez-Vizuete, Jose Maria, Martinez-Alfaro, Elisa · 2021 · Rheumatology
50. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU
    Elinor Tan, Jialu Song, Adam M. Deane, Mark Philip Plummer · 2020 · CHEST Journal
51. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
    Ronald Andrew Seaton, Cheryl Gibbons, Lesley Cooper, William Malcolm, Rachel McKinney, Stephanie Dundas, David M Griffith, Danielle Jeffreys, Kayleigh Hamilton, Brian Choo‐Kang et al. · 2020 · Journal of Infection
52. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?
    Bektas, Arsun, Schurman, Shepherd H., Franceschi, Claudio, Ferrucci, Luigi · 2020 · Immunity & Ageing
53. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
    Parastoo Tarighi, Samane Eftekhari, Milad Chizari, Mahsa Sabernavaei, Davod Jafari, Parastoo Mirzabeigi · 2021 · European Journal of Pharmacology
54. The COVID-19 pandemic: consequences for nephrology
    Annette N. Bruchfeld · 2020 · Nature Reviews Nephrology
55. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region
    Gauthier Blonz, Achille Kouatchet, Nicolas Chudeau, Emmanuel Pontis, Julien Lorber, Anthony Lemeur, Lucie Planche, Jean-Baptiste Lascarrou, Gwenhaël Colin · 2021 · Critical Care
56. Monocyte activation in systemic Covid-19 infection: Assay and rationale
    Fernando O. Martínez, Theo Combes, Federica Orsenigo, Siamon Gordon · 2020 · EBioMedicine
57. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Niraj Konchady Shenoy, Rebecca A. Luchtel, Perminder Gulani · 2020 · BMC Medicine
58. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
    Jason D. Goldman, Philip Cameron Robinson, Thomas S. Uldrick, Per T Ljungman · 2021 · Journal for ImmunoTherapy of Cancer
59. Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
    John P. A. Ioannidis · 2021 · European Journal of Clinical Investigation
60. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
    Charlotte Kaeuffer, Coralie Le Hyaric, Thibaut Fabacher, Joy Mootien, Benjamin Dervieux, Yvon Ruch, Antonin Hugerot, Yves-Jean Zhu, Valentin Pointurier, Raphaël Clère-Jehl et al. · 2020 · Eurosurveillance
61. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice
    Thomas Brendler, Ahmed Al‐Harrasi, Rudolf Bauer, Stefan Gafner, Mary L Hardy, Michael Heinrich, Hossein Hosseinzadeh, Angelo Antonio Izzo, Martin Michaelis, Marjan Nassiri‐Asl et al. · 2020 · Phytotherapy Research
62. Current Strategies of Antiviral Drug Discovery for COVID-19
    Miao Mei, Xu Tan · 2021 · Frontiers in Molecular Biosciences
63. Hematological Abnormalities in COVID-19: A Narrative Review
    Asma Rahman, Roshan Niloofa, Umesh Jayarajah, Sanjay De Mel, Visula Abeysuriya, Suranjith Luke Seneviratne · 2021 · American Journal of Tropical Medicine and Hygiene
64. Compartmental immunophenotyping in COVID-19 ARDS: A case series
    Andreas Ronit, Ronan M. G. Berg, Jakob Thaning Bay, Anna Karen Haugaard, Magnus Glindvad Ahlström, Kristoffer Sølvsten Burgdorf, Henrik Ullum, Sara Bird Rørvig, Klaus Tjelle Kristiansen, Nicolai Bang Foss et al. · 2020 · Journal of Allergy and Clinical Immunology
65. The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Evgeny Lvovich Nasonov, Samsonov MIu · 2020 · Biomedicine & Pharmacotherapy
66. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
    Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana · 2021 · Frontiers in Pharmacology
67. Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
    Yuhui Zhang, Andrew J.S. Coats, Zhe Zheng, Marianna Adamo, Giuseppe Ambrosio, Stefan D. Anker, Javed Butler, Dingli Xu, Jingyuan Mao, Muhammad Shahzeb Khan et al. · 2020 · European Journal of Heart Failure
68. The cytokine storm and thyroid hormone changes in COVID-19
    Laura Croce, Dave Gangemi, G. Ancona, Federico Liboà, Giulia Bendotti, L. Minelli, L. Chiovato · 2021 · Journal of Endocrinological Investigation
69. Methylprednisolone in adults hospitalized with COVID-19 pneumonia
    Luís Corral-Gudino, Alberto Bahamonde, Francisco Arnaiz-Revillas, Julia Gómez Barquero, Jesica Abadía-Otero, Carmen García‐Ibarbia, Victor Mora, Ana Cerezo-Hernández, Ana Cerezo-Hernández, Graciela López-Muñíz et al. · 2021 · Wiener klinische Wochenschrift
70. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis
    Vincenzo Cardinale, Gabriele Capurso, Gianluca Ianiro, Antonio Gasbarrini, Paolo Giorgio Arcidiacono, Domenico Alvaro · 2020 · Digestive and Liver Disease
71. Efficacy of Remdesivir in COVID-19
    Erin K McCreary, Derek Angus · 2020 · JAMA
72. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
    J. Tardif, N. Bouabdallaoui, Philippe L. L'Allier et al. · 2021 · medRxiv
73. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
    Maja Buszko, Jung‐Hyun Park, Daniela I. Verthelyi, Ranjan Sen, Howard A. Young, Amy S. Rosenberg · 2020 · Nature Immunology
74. Blood DNA methylation and COVID-19 outcomes
    Joseph Balnis, Andy Madrid, Kirk J. Hogan, Lisa A. Drake, Hau Chieng, Anupama Tiwari, Catherine E. Vincent, Amit Chopra, Peter A. Vincent, Michael D. Robek et al. · 2021 · Clinical Epigenetics
75. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature
    Lucia Novelli, Francesca Motta, Maria De Santis, Aftab Ahmed Ansari, Merrill Eric Gershwin, Carlo Francesco Selmi · 2020 · Journal of Autoimmunity
76. Severe organising pneumonia following COVID-19
    István Vadász, Faeq Husain‐Syed, Peter Dorfmüller, Fritz Christian Roller, Khodr Tello, Matthias Hecker, Rory Edward Morty, Stefan Gattenlöhner, Hans‐Dieter Walmrath, Friedrich Grimminger et al. · 2020 · Thorax
77. SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
    Pierre D. Kory, Jeffrey P. Kanne · 2020 · BMJ Open Respiratory Research
78. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study
    Monique Freire Santana, Mayla Gabriela Silva Borba, Djane Clarys Baía-da-Silva, Fernando Val, Márcia Almeida Araújo Alexandre, José Diego Brito-Sousa, Gisely Cardoso de Melo, Marcos Vinícius Oliveira Queiroga, Maria Eduarda Leão de Farias, Cecília Cunha Camilo et al. · 2020 · American Journal of Tropical Medicine and Hygiene
79. KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response
    Justin Reese, Deepak Raveendran Unni, Tiffany J. Callahan, Luca Cappelletti, Vida Ravanmehr, Seth Carbon, Tommaso Fontana, Hannah Blau, Nicolas Matentzoglu, Nomi L. Harris et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
80. Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
    Balaji Krishnamachary, Christine M. Cook, Ashok Kumar, Leslie A. Spikes, Prabhakar Chalise, Navneet Kaur Dhillon · 2021 · Journal of Extracellular Vesicles
81. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Ken R. Walder, Michael Berk, LISA S. OLIVE, Andre Ferrer Carvalho et al. · 2021 · Cytokine
82. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
    Jeffrey R. Strich, Marcos Javier Ramos-Benítez, Davide Randazzo, Sydney R. Stein, Ashley L. Babyak, Richard T. Davey, Anthony F. Suffredini, Richard W. Childs, Daniel S. Chertow · 2020 · The Journal of Infectious Diseases
83. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
84. Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
    Charles Agbuduwe, Supratik Basu · 2020 · European Journal Of Haematology
85. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
    Barh, Debmalya, Tiwari, Sandeep, Weener, Marianna E., Azevedo, Vasco, Góes-Neto, Aristóteles, Gromiha, M. Michael, Ghosh, Preetam · 2020 · Computers in Biology and Medicine
86. A practical guide for the management of steroid induced hyperglycaemia in the hospital
    Aberer, Felix, Hochfellner, Daniel A., Sourij, Harald, Mader, Julia K. · 2021 · Journal of Clinical Medicine
87. Bacterial and fungal superinfections in critically ill patients with COVID-19
    Matteo Bassetti, Marin H. Kollef, JF Timsit · 2020 · Intensive Care Medicine
88. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
    Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Megan Gallogly, Marcos J. G. De Lima, Muhammad Rizwan Sohail · 2020 · Virology Journal
89. A case series of invasive mucormycosis in patients with COVID-19 infection
    N. Mishra, V. S. Mutya, Alphonsa Thomas · 2021
90. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19
    Justine J. Ko, Clay Wu, Neha Mehta, Noah Wald‐Dickler, Wei Yang, Renli Qiao · 2021 · Journal of Intensive Care Medicine
91. Calcifediol Treatment and COVID-19–Related Outcomes
    Xavier Nogués, Diana Ovejero, Marta Pineda Moncusí, Roger Bouillon, Dolors Arenas, Julio Pascual, Anna Ribes, Robert Güerri‐Fernández, Judit Villar-García, Abora Rial‐Villavecchia et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
92. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children
    Zahra Belhadjer, Johanne Auriau, Mathilde Méot, Mehdi Oualha, Sylvain Renolleau, Lucile Houyel, Damien Bonnet · 2020 · Circulation
93. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
    Muhammad Tahir ul Qamar, Farah Shahid, S. Aslam, U. Ashfaq, Sidra Aslam, Israr Fatima, Muhammad Mazhar Fareed, A. Zohaib, Ling-Ling Chen · 2020 · Infectious Diseases of Poverty
94. Sex‐related differences in COVID‐19 lethality
    Claudia Renata Rezende Penna, Valentina Mercurio, Carlo Gabriele Tocchetti, Pasquale Pagliaro · 2020 · British Journal of Pharmacology
95. Intensive care management of patients with COVID-19: a practical approach
    Ludhmila Abrahão Hajjar, Isabela Bispo Santos da Silva Costa, Stéphanie Itala Rizk, Bruno Biselli, Brenno Rizerio Gomes, Cristina Salvadori Bittar, Gisele Queiroz de Oliveira, Juliano Pinheiro de Almeida, Mariana Vieira de Oliveira Bello, Cibele Larrosa Garzillo et al. · 2021 · Annals of Intensive Care
96. The place for remdesivir in COVID-19 treatment
    Barnaby Edward Young, Thuan Tong Tan, Yee‐Sin Leo · 2020 · The Lancet Infectious Diseases
97. Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza
    Natalie L. Cobb, Neha Alhad Sathe, Kevin I. Duan, Kevin P. Seitz, Matthew R. Thau, Clifford C. Sung, Eric D. Morrell, Carmen R. Mikacenic, Hyungsu Kim, Wayne Conrad Liles et al. · 2020 · Annals of the American Thoracic Society
98. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
    Fabrizio Cantini, Delia Goletti, Linda Petrone, Saeid Najafi Fard, Laura Niccoli, Rosario Foti · 2020 · Drugs
99. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
    Igor Andrade Santos, Victória Riquena Grosche, Fernando R.G. Bergamini, Robinson Sabino Silva, Ana Carolina Gomes Jardim · 2020 · Frontiers in Microbiology
100. Single-cell immunology of SARS-CoV-2 infection
     Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, Michael A. Zager, Evan William Newell, Raphaël Gottardo · 2021 · Nature Biotechnology